The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

Over one million people in Spain live with pacemakers, ICDs or cardiac resynchronisation devices. The introduction of the ...

A dissolvable pacemaker that’s smaller than a grain of rice and powered by light could become an invaluable tool for saving the lives of newborn infants., The device can be implanted noninvasively via ...